1. European Urology Oncology
PD-L1 Expression in Men with Penile Cancer and its Association with Clinical Outcomes 
Sabina Davidsson, Jessica Carlsson, Francesca Giunchi, Alyssa Harlow, Peter Kirrander, Jennifer Rider, Michelangelo Fiorentino, Ove Andrén 
European Urology Oncology 
DOI: /j.euo
Copyright © 2018 European Association of Urology Terms and Conditions

2. Fig. 1
PD-L1 protein expression in tumor cells and tumor-infiltrating immune (TII) cells in penile squamous cell carcinoma specimens (brown chromogen). PD-L1 positivity in (A) tumor cells and (B) TII cells detected with anti-PD-L1 antibody clone SP142. (C) PD-L1 positivity in (C) tumor cells and (D) TII cells detected with anti-PD-L1 antibody clone Magnification 10× for all images.
European Urology Oncology DOI: ( /j.euo )
Copyright © 2018 European Association of Urology Terms and Conditions

3. Fig. 2
Kaplan-Meier curve showing that patients with penile squamous cell carcinoma with PD-L1 expression in tumor cells, detected with anti-PD-L1 antibody clone SP142, have shorter cancer-specific survival than patients without PD-L1 expression in tumor cells. Product-limit survival estimates with 95% Hall-Wellner and equal precision bands.
European Urology Oncology DOI: ( /j.euo )
Copyright © 2018 European Association of Urology Terms and Conditions

4. Fig. 3
Kaplan-Meier curve showing that patients with penile squamous cell carcinoma with PD-L1 expression in tumor cells, detected with anti-PD-L1 antibody clone 28.8, have shorter cancer-specific survival than patients without PD-L1 expression in tumor cells. Product-limit survival estimates with 95% Hall-Wellner and equal precision bands.
European Urology Oncology DOI: ( /j.euo )
Copyright © 2018 European Association of Urology Terms and Conditions